Sign in

Acuta Capital Partners, LLC

CIK:0001582844
Hedge Fund
$154M AUM
28 holdings
Belmont, CA, United States
Founded:2011
5 employees
Latest filing:Jun 30, 2025

Acuta Capital Partners, LLC is an investment management firm headquartered in Belmont, California, United States. Founded in 2011 and primarily owned by Anupam Dalal, who serves as Managing Member, the firm specializes in providing investment advisory services. With approximately 5 employees, Acuta Capital Partners operates pooled investment vehicles and serves accredited institutional clients and high-net-worth individuals.

Investment Strategy

Acuta Capital Partners focuses on managing pooled investment vehicles, investing in publicly traded equities with an emphasis on healthcare and biotechnology sectors. The firm utilizes fundamental analysis and a long/short equity strategy, aiming to generate absolute returns while managing downside risk. Investment decisions are based on intensive research and bottom-up analysis, frequently targeting innovative companies in life sciences and therapeutics.

Top Buys
C
CDTXCIDARA THERAPEUTICS INC
+$6.0M
J
JAZZJAZZ PHARMACEUTICALS PLC
+$1.6M
T
TSHATAYSHA GENE THERAPIES INC
+$1.1M
A
AKROAKERO THERAPEUTICS INC
+$1.1M
T
TERNTERNS PHARMACEUTICALS INC
+$831.7K
Top Sells
E
ELVNENLIVEN THERAPEUTICS INC
-$5.2M
I
INSMINSMED INC
-$4.4M
T
TRVITREVI THERAPEUTICS INC
-$2.2M
M
MRKMERCK & CO
-$2.1M
T
TRMLTOURMALINE BIO INC
-$2.0M

Top Holdings

O
OCULOCULAR THERAPEUTIX INC
+13.1%$9.4M
C
CDTXCIDARA THERAPEUTICS INC
+12.2%$8.7M
A
AADIWHITEHAWK THERAPEUTICS INC
+8.9%$6.4M
S
SLNOSOLENO THERAPEUTICS INC
+7.4%$5.3M
T
TRMLTOURMALINE BIO INC
+6.3%$4.5M

Equity Positions (26)

TickerSecurityWeightMarket ValueSharesAvg CostPriceChange (QoQ)
O
OCUL
OCULAR THERAPEUTIX INC13.15%$9.4M1,014,940$6.66$9.28+$478.1K
C
CDTX
CIDARA THERAPEUTICS INC12.21%$8.7M179,569$31.31$48.71+$6.0M
A
AADI
WHITEHAWK THERAPEUTICS INC8.90%$6.4M3,410,402$15.31$1.71+$306.9K
S
SLNO
SOLENO THERAPEUTICS INC7.42%$5.3M63,436$71.45$83.78+$517.8K
T
TRML
TOURMALINE BIO INC6.33%$4.5M283,682$23.46$15.99-$2.0M

Industry Allocation

PHARMACEUTICAL PREPARATIONS
+57.6%
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
+30.3%
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
+7.4%
BLANK CHECKS
+2.8%

Investment Team (2)

NameRoleLocationLinkedIn
J
James P.
Acuta Capital PartnersUnited States
Kevin Hong
Kevin Hong
AnalystSan Jose, CA , United States